First Trust Advisors
IBRX icon

First Trust Advisors’s ImmunityBio IBRX Stock Holding History

First Trust Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
+1,214,667
New +$9.19M 0.01% 1192
2025
Q4 		– Sell
-271,832
Closed -$669K – 2670
2025
Q3 		$669K Sell
271,832
-276,674
-50% -$713K ﹤0.01% 2240
2025
Q2 		$1.45M Buy
+548,506
New +$1.47M ﹤0.01% 1950
2025
Q1 		– Sell
-167,200
Closed -$428K – 2575
2024
Q4 		$428K Sell
167,200
-589,609
-78% -$2.46M ﹤0.01% 2295
2024
Q3 		$2.82M Sell
756,809
-130,811
-15% -$605K ﹤0.01% 1616
2024
Q2 		$5.61M Buy
+887,620
New +$5.85M 0.01% 1216
2023
Q2 		– Sell
-155,497
Closed -$283K – 2392
2023
Q1 		$283K Buy
155,497
+97,090
+166% +$302K ﹤0.01% 2248
2022
Q4 		$296K Sell
58,407
-16,962
-23% -$93.1K ﹤0.01% 2315
2022
Q3 		$375K Buy
75,369
+14,897
+25% +$67.9K ﹤0.01% 2295
2022
Q2 		$225K Buy
+60,472
New +$243K ﹤0.01% 2364
2021
Q3 		– Sell
-250,096
Closed -$3.57M – 2568
2021
Q2 		$3.57M Sell
250,096
-60,824
-20% -$1M ﹤0.01% 1559
2021
Q1 		$7.38M Buy
310,920
+190,101
+157% +$4.93M 0.01% 1050
2020
Q4 		$1.61M Buy
+120,819
New +$1.16M ﹤0.01% 1690

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Trust Advisors's IBRX Position: Q2 2026 in Review

First Trust Advisors opened a new position in ImmunityBio (IBRX) in Q2 2026: 1,214,667 shares worth $10.6M. The stake represents 0.01% of the portfolio and ranks #1192 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in IBRX as recently as Q3 2025.

First Trust Advisors first reported a position in IBRX in Q4 2020 and has held it in 13 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • First Trust Advisors held 1,214,667 shares of ImmunityBio worth $10.6M as of Q2 2026.
  • ImmunityBio was a new First Trust Advisors position in Q2 2026.
  • ImmunityBio made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1192 holding.
  • First Trust Advisors first reported a position in ImmunityBio in Q4 2020 and has held it in 13 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.